REVO BIOLOGICS

100 E Boone St, Redfield, Arkansas, United States

Also known as:

tsi redfield laboratories

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

80.0%

Phase 1

20.0%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (5)

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Phase 3

Completed

interventional

Jul 2014120 participants

Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

Phase 3

Completed

interventional

Apr 201427 participants

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Phase 1

Completed

interventional

Oct 201215 participants

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Phase 3

Completed

interventional

Apr 200518 participants

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Phase 3

Completed

interventional

Dec 200214 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations